GSK2636771 is a potent, orally bioavailable and selective inhibitor of PI3K (0.89 nM), with >900-fold selectivity over PI3K/PI3K and >10-fold over PI3K. It inhibits AKT phosphorylation and downstream signalling measured as decrease of PRAS40-, GSK3-, and RPS6-phosphorylation in PTEN mutant cell lines.
For research use only. We do not sell to patients.
Name | GSK2636771 |
---|---|
Iupac Chemical Name | 2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid |
Synonyms | GSK-2636771,GSK 2636771 |
Molecular Formula | C22H22F3N3O3 |
Molecular Weight | 433.42 |
Smile | CC1=NC2=C(N1CC1=C(C(=CC=C1)C(F)(F)F)C)C=C(C=C2C(=O)O)N2CCOCC2 |
InChiKey | XTKLTGBKIDQGQL-UHFFFAOYSA-N |
InChi | InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30) |
CAS Number | 1372540-25-4 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | solid |
---|---|
Purity | 98% by HPLC |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |